Clinical Trial Update: Voxelotor for Improving Oxygen Saturation in Adults [Phase 2]

View source ↗

Summary

A Phase 2 trial of voxelotor to improve oxygen saturation in adults with acute lung injury or end-stage lung disease was terminated; results were posted on 2024…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Lung Disease
• Lung Injury

Drugs mentioned

• Oxbryta (voxelotor) (voxelotor)

Snippet

Sponsor: Duke University | Conditions: Acute Lung Injury, End Stage Lung Disease | Phase 2 | Status: TERMINATED | Results posted: 2024-07-24